Biodesix Files 8-K on Security Holder Rights and Bylaws
Ticker: BDSX · Form: 8-K · Filed: Sep 15, 2025 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, legal
TL;DR
Biodesix 8-K: Changes to security holder rights and bylaws filed 9/15.
AI Summary
Biodesix, Inc. filed an 8-K on September 15, 2025, reporting material modifications to security holder rights and amendments to its articles of incorporation or bylaws. The filing also includes financial statements and exhibits. The report covers events up to September 12, 2025.
Why It Matters
This filing indicates potential changes in the rights of Biodesix's security holders and amendments to its corporate governance documents, which could impact investors.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not immediately indicate significant financial distress or operational risk.
Key Numbers
- 001-39659 — SEC File Number (Identifies the company's SEC filing history.)
- 20-3986492 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- BIODESIX INC (company) — Registrant
- 0001193125-25-203746 (filing_id) — Accession Number
- 20250915 (date) — Filing Date
- 20250912 (date) — Period of Report
- Delaware (jurisdiction) — State of Incorporation
- Louisville, CO (location) — Principal Executive Offices
FAQ
What specific modifications were made to the rights of security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' but does not detail the specific changes within the provided text.
What are the key amendments to Biodesix's Articles of Incorporation or Bylaws?
The filing lists 'Amendments to Articles of Incorporation or Bylaws' as an item, but the specific amendments are not detailed in this excerpt.
When was the report filed with the SEC?
The report was filed on September 15, 2025.
What is the principal executive office address for Biodesix, Inc.?
The principal executive offices are located at 919 West Dillon Rd., Louisville, CO 80027.
What is the SIC code for Biodesix, Inc.?
The Standard Industrial Classification (SIC) code is 8071, which corresponds to Medical Laboratories.
Filing Stats: 876 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2025-09-15 17:01:20
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share BDSX The Nasdaq Stock Mar
Filing Documents
- d14130d8k.htm (8-K) — 29KB
- d14130dex31.htm (EX-3.1) — 8KB
- d14130dex32.htm (EX-3.2) — 8KB
- 0001193125-25-203746.txt ( ) — 166KB
- bdsx-20250912.xsd (EX-101.SCH) — 3KB
- bdsx-20250912_lab.xml (EX-101.LAB) — 18KB
- bdsx-20250912_pre.xml (EX-101.PRE) — 11KB
- d14130d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Biodesix, Inc. 3.2 Certificate of Elimination of the Series A Non-Voting Convertible Preferred Stock of Biodesix, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 15, 2025 BIODESIX, INC. By: /s/ Robin Harper Cowie Name: Robin Harper Cowie Title: Chief Financial Officer